Search
for
Sort by
Research 241–270 of 1000+
- Clinical Evidence of Increase in Hair Growth and Decrease in Hair Loss without Adverse Reactions Promoted by the Commercial Lotion ECOHAIR®
- Adverse events with finasteride or dutasteride: FAERS
- 392 Hair loss after drug reaction with eosinophilia and systemic symptoms: A multicentric retrospective study
- Immunologic adverse reactions of β-blockers and the skin (Review)
- Anticonvulsant-Induced Cutaneous Reactions
- A Gender Hypothesis of sex disparities in adverse drug events
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- Six-year Retrospective Review of Drug Reaction with Eosinophilia and Systemic Symptoms
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports
- Risk of muscular adverse effects with finasteride
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Dermatological adverse events with taxane chemotherapy
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- How much medication is delivered in a novel drug delivery technique that uses a tattoo machine?
- Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Case reports suggest a broader range of sexual adverse events in patients receiving finasteride [Propecia, Proscar] than previously reported,
- Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- Viral reactivation in hospitalized patients with drug reaction with eosinophilia and systemic symptoms: A retrospective study from a tertiary medical center in the United States
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System